Riskpilot← Back to searchSign inGet full accessOxy-Viva Sweden AB
ABIn liquidationOrg 5568771546Bomhusgatan 4Production of electricity from renewable sources · NACE 3512Est. 20110 employees
Revenue 2022
SEK 536K
+73% vs 2021
EBITDA margin
48.9%
+4267% vs 2021
Equity ratio
95.2%
Financial strength
Net profit 2022
SEK 219K
+1785% vs 2021
| Revenue | SEK 536K | +73% |
| EBITDA | SEK 262K | +4267% |
| Net profit | SEK 219K | +1785% |
| Total assets | SEK 413K | +12% |
| Equity | SEK 393K | +126% |
| Employees | 0 | — |
Legal name
Oxy-Viva Sweden AB
Org number
5568771546
Legal form
Aktiebolag
NACE code
3512 · Production of electricity from renewable sources
Founded
20 december 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget ska bedriva verksamhet inom konstruktion av biologiska luftfilter.
Address
Bomhusgatan 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 374 | 362 | 127 | 310 | 536 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 157 | 43 | −94 | 6 | 262 |
| Depreciation & amort. | −18 | −18 | −18 | −18 | −0 |
| EBIT | 139 | 25 | −112 | −12 | 262 |
| Net financials | — | — | −1 | −1 | −2 |
| Profit before tax | 115 | 24 | −89 | −13 | 259 |
| Tax | −16 | −5 | −0 | −0 | −40 |
| Net profit | 99 | 19 | −89 | −13 | 219 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 550 | 473 | 362 | 369 | 413 |
| Equity | 257 | 276 | 187 | 174 | 393 |
| Long-term debt | 200 | 100 | 100 | 100 | 40 |
| Short-term debt | 69 | 74 | 75 | 95 | 61 |
| Total debt | 269 | 174 | 175 | 195 | 101 |
EBITDA margin
48.9%
This company
15.8%
Market median
+209% vs market
20182022
Equity ratio
95.2%
This company
38.2%
Market median
+149% vs market
20182022
Return on equity
55.7%
This company
18.4%
Market median
+203% vs market
20182022
Net profit margin
40.9%
This company
8.1%
Market median
+405% vs market
20182022
Asset turnover
1.30×
This company
1.12×
Market median
+16% vs market
20182022
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AC Liquidator | Liquidator | 2025 |
| Former (1) | ||
KO Audit | Audit | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
| Board of Directors | 2022 – 2022 | |
| Chairman | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Oxy-Viva Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Cecilia Cilla Lindahl | Liquidator | 0 companies |
| Kent Ove Olsson | Audit | 0 companies |
| Lars Gösta Skoglund | Board of Directors | 0 companies |
| Hans Olof Bergseje | Chairman | 0 companies |
| Carl Olof Bergseje | Deputy Board Member | 0 companies |
| Eva Christine Bergseje | Deputy Board Member | 0 companies |